MARKET

ACIU

ACIU

AC Immune
NASDAQ
1.680
+0.020
+1.20%
After Hours: 1.680 0 0.00% 16:05 05/09 EDT
OPEN
1.680
PREV CLOSE
1.660
HIGH
1.700
LOW
1.660
VOLUME
69.06K
TURNOVER
--
52 WEEK HIGH
4.978
52 WEEK LOW
1.430
MARKET CAP
168.69M
P/E (TTM)
-2.8508
1D
5D
1M
3M
1Y
5Y
1D
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating
TipRanks · 5d ago
Weekly Report: what happened at ACIU last week (0428-0502)?
Weekly Report · 6d ago
Analysts’ Top Healthcare Picks: AC Immune SA (ACIU), Praxis Precision Medicines (PRAX)
TipRanks · 6d ago
AC Immune Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/01 12:59
AC Immune Price Target Cut to $12.00/Share From $16.00 by HC Wainwright & Co.
Dow Jones · 05/01 12:59
HC Wainwright & Co. Maintains Buy on AC Immune, Lowers Price Target to $12
Benzinga · 05/01 12:49
AC Immune price target lowered to $12 from $16 at H.C. Wainwright
TipRanks · 05/01 10:12
AC Immune Q1 EPS $(0.21) Misses $(0.20) Estimate, Sales $1.10M Beat $300.67K Estimate
Benzinga · 04/30 13:26
More
About ACIU
More
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
Recently
Symbol
Price
%Change

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.